|
DE1047991B
(de)
|
1957-11-20 |
1958-12-31 |
Nordmark Werke Gmbh |
Verfahren zur Herstellung chemisch stabiler, untoxischer, steriler Injektionsloesungen von Thioctsaeure
|
|
US3875207A
(en)
|
1967-01-25 |
1975-04-01 |
Ciba Geigy Corp |
Process for the temporary protection of amino groups in peptide syntheses
|
|
US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
|
CA1219824A
(en)
|
1981-04-17 |
1987-03-31 |
David C. Ward |
Modified nucleotides and methods of preparing and using same
|
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
|
US5288706A
(en)
|
1987-12-25 |
1994-02-22 |
Mitsui Toatsu Chemicals, Incorporated |
Medicament for prevention and remedy of diseases of the pancreas and others
|
|
US5039660A
(en)
|
1988-03-02 |
1991-08-13 |
Endocon, Inc. |
Partially fused peptide pellet
|
|
FR2653334B1
(fr)
|
1989-10-19 |
1991-12-20 |
Erphar Ste Civile |
Preparation cosmetique de bronzage.
|
|
DE59010810D1
(de)
|
1989-11-09 |
1998-04-16 |
Asta Medica Ag |
Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
|
|
DE4000397A1
(de)
|
1990-01-09 |
1991-07-11 |
Hoechst Ag |
Lipidselektive antioxidantien sowie deren herstellung und verwendung
|
|
CA2118496C
(en)
|
1992-04-24 |
2005-01-11 |
Roger Randall Charles New |
Method of reducing microorganism adhesion
|
|
DE4235912C2
(de)
|
1992-10-23 |
2002-12-05 |
Viatris Gmbh |
Verfahren zur Herstellung kristalliner Thioctsäure und deren Verwendung
|
|
DE4433764A1
(de)
|
1994-09-22 |
1996-03-28 |
Asta Medica Ag |
Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
|
|
WO1997000889A1
(en)
|
1995-06-21 |
1997-01-09 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Peptides binding to low-density lipoproteins
|
|
JPH0990542A
(ja)
|
1995-09-28 |
1997-04-04 |
Konica Corp |
ハロゲン化銀写真感光材料
|
|
FR2741075B1
(fr)
|
1995-11-15 |
1998-01-30 |
Rech De Pathologie Appliquee S |
Conjugues peptidiques, leur utilisation a titre de medicament et compositions les contenant
|
|
CA2264485A1
(en)
|
1996-09-06 |
1998-03-12 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Gata-6 transcription factor: compositions and methods
|
|
IL123887A0
(en)
|
1997-04-02 |
1998-10-30 |
Sankyo Co |
Dithiolan derivatives their use and pharmaceutical compositions containing the same
|
|
JPH117099A
(ja)
|
1997-06-13 |
1999-01-12 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
|
US6090842A
(en)
|
1998-03-10 |
2000-07-18 |
The Regents Of The University Of California |
Lipoic acid analogs
|
|
DE19834608A1
(de)
|
1998-07-31 |
2000-02-03 |
Basf Ag |
Kristallmodifikation der Liponsäure
|
|
JP2000169371A
(ja)
|
1998-10-02 |
2000-06-20 |
Sankyo Co Ltd |
ジチオラン誘導体を含有する医薬
|
|
EP1133317A1
(de)
|
1998-11-26 |
2001-09-19 |
Pentapharm AG |
Transportsystemkonjugate
|
|
US7214658B2
(en)
|
2004-07-06 |
2007-05-08 |
Tact Ip, Llc |
Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection
|
|
WO2001009118A2
(en)
|
1999-07-29 |
2001-02-08 |
Patrick T Prendergast |
Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
|
|
CA2389429C
(en)
|
1999-11-18 |
2012-05-29 |
Victor E. Shashoua |
Compositions and methods for counteracting effects of reactive oxygen species and free radicals
|
|
US6890896B1
(en)
|
1999-11-18 |
2005-05-10 |
Ceremedix, Inc. |
Compositions and methods for counteracting effects of reactive oxygen species and free radicals
|
|
US6664287B2
(en)
|
2000-03-15 |
2003-12-16 |
Bethesda Pharmaceuticals, Inc. |
Antioxidants
|
|
WO2001080851A1
(en)
*
|
2000-04-21 |
2001-11-01 |
United States Army Medical Research And Materiel Command |
Method of treating, preventing or inhibiting central nervous system injuries and diseases
|
|
JP2002189271A
(ja)
|
2000-12-21 |
2002-07-05 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料およびその処理方法
|
|
EP1371640B1
(en)
|
2001-03-19 |
2009-10-28 |
Senju Pharmaceutical Co., Ltd. |
Novel a-lipoic acid derivative and use thereof
|
|
JP2005515156A
(ja)
|
2001-05-25 |
2005-05-26 |
セレメディックス，インク． |
反応性酸素種およびフリーラジカルの効力を中和するための単一アミノ酸に基づく化合物
|
|
JP4259813B2
(ja)
|
2001-05-29 |
2009-04-30 |
千寿製薬株式会社 |
α−リポイルアミノ酸の安定化法および安定化されたα−リポイルアミノ酸を含有する水性液剤
|
|
DE10163836A1
(de)
|
2001-12-22 |
2003-07-10 |
Friz Biochem Gmbh |
Multifunktionales Reagenz zur Synthese von thiolmodifizierten Oligomeren
|
|
WO2003055853A1
(en)
|
2001-12-26 |
2003-07-10 |
Nippon Soda Co., Ltd. |
Electron-accepting compounds capable of forming self-assembled monolayers
|
|
AUPS065102A0
(en)
|
2002-02-20 |
2002-03-14 |
Unisearch Limited |
Fluorous acetalation
|
|
EP1476440A4
(en)
|
2002-02-22 |
2005-06-01 |
Albany College Of Pharmacy |
METHODS AND COMPOUNDS USEFUL IN INHIBITION BY RADICAL AND / OR OXIDIZING AGGRESSION AND IN THE TREATMENT AND PREVENTION OF DISEASE
|
|
JP2003286168A
(ja)
|
2002-03-28 |
2003-10-07 |
Senju Pharmaceut Co Ltd |
α−リポイルアミノ酸を含有する皮膚外用剤
|
|
JP4376540B2
(ja)
|
2002-05-31 |
2009-12-02 |
アイバイツ株式会社 |
金属表面修飾剤および新規含硫黄化合物
|
|
US7030154B2
(en)
|
2002-06-07 |
2006-04-18 |
Juvenon, Inc. |
Stability of lipoic acid
|
|
TWI331034B
(en)
|
2002-07-08 |
2010-10-01 |
Piramal Life Sciences Ltd |
Inhibitors of cyclin-dependent kinases and their use
|
|
CA2492807A1
(en)
|
2002-07-29 |
2004-03-04 |
Nanodel Technologies Gmbh |
Nanoparticles for dna administration to a target organ
|
|
US8603345B2
(en)
|
2003-02-13 |
2013-12-10 |
Becton, Dickinson And Company |
Devices for component removal during blood collection, and uses thereof
|
|
EP1454627A1
(en)
|
2003-03-06 |
2004-09-08 |
MyoContract Ltd. |
Alpha-Keto carbonyl calpain inhibitors
|
|
US20040204340A1
(en)
|
2003-04-11 |
2004-10-14 |
Guilford Pharmaceuticals, Inc. |
Polyprolyl inhibitors of cyclophilin
|
|
US7202270B2
(en)
|
2003-06-20 |
2007-04-10 |
Sami Labs Limited |
Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses
|
|
WO2005063732A1
(en)
|
2003-12-23 |
2005-07-14 |
Microbia, Inc. |
Compounds and methods for the treatment of asthma
|
|
EP1726596A4
(en)
|
2004-02-18 |
2009-08-26 |
Japan Science & Tech Agency |
SUGAR CHAIN LIGAND COMPOSITE COMPOUND AND PROCESS FOR PROTEIN ANALYSIS WITH THE LIGAND COMPOSITE COMPOUND
|
|
JP2006022066A
(ja)
|
2004-07-09 |
2006-01-26 |
Shiseido Co Ltd |
重合抑制剤および即時型黒化防止用皮膚外用剤
|
|
WO2006101909A2
(en)
|
2005-03-16 |
2006-09-28 |
Ischemix, Inc. |
Combination therapy for treating or preventing diseases
|
|
WO2006101910A2
(en)
|
2005-03-16 |
2006-09-28 |
Ischemix, Inc. |
Peptide compounds and methods of using peptide compounds to treat conditions affecting the cardiac, pulmonary, and nervous systems
|
|
JP2008174453A
(ja)
|
2005-04-28 |
2008-07-31 |
Iwaki Kk |
頭皮脱毛治療剤
|
|
US8507439B2
(en)
*
|
2005-08-29 |
2013-08-13 |
Angela Shashoua |
Neuroprotective and neurorestorative method and compositions
|
|
JP4951226B2
(ja)
|
2005-09-08 |
2012-06-13 |
立山化成株式会社 |
α−リポ酸アルカリ塩の製法
|
|
WO2007030581A2
(en)
|
2005-09-09 |
2007-03-15 |
Oregon Health & Science University |
Neuroprotectants
|
|
DE602006013787D1
(de)
|
2006-03-28 |
2010-06-02 |
Epitech Group Srl |
Eine Pharmazeutische Zusammensetzung zur Behandlung von Pathologien, die durch die allgemeine Immunantwort verursacht werden
|
|
US20080051691A1
(en)
|
2006-08-28 |
2008-02-28 |
Wyeth |
Implantable shunt or catheter enabling gradual delivery of therapeutic agents
|
|
JP2012508165A
(ja)
|
2008-11-07 |
2012-04-05 |
イスティテュート ビオキーミコ ナッツィオナーレ サーヴィオ エスアールエル |
α−リポ酸誘導体及び薬物製剤へのそれらの使用
|
|
US7928067B2
(en)
|
2009-05-14 |
2011-04-19 |
Ischemix Llc |
Compositions and methods for treating ischemia and ischemia-reperfusion injury
|
|
US8080674B2
(en)
|
2009-06-12 |
2011-12-20 |
Ampac Fine Chemicals Llc. |
Preparation of polymer-free R-(+)-α-lipoic acid magnesium salt
|
|
EP2821405B1
(en)
|
2009-06-15 |
2016-04-13 |
Encore Health, LLC |
Choline esters for treating presbyopia and cataract
|
|
EP3069612A3
(en)
|
2009-06-15 |
2016-10-19 |
Encore Health, LLC |
Dithiol compounds, derivatives, and uses therefor
|
|
IT1397154B1
(it)
|
2010-01-04 |
2013-01-04 |
Ghelardini |
Composti ad efficacia sia analgesica che antiperalgesica.
|
|
DK2640423T3
(en)
|
2010-11-18 |
2017-10-02 |
Ischemix Llc |
LIPOYL COMPOUNDS AND THEIR USE IN TREATMENT OF ISchemic DAMAGE
|
|
US20150329519A1
(en)
|
2014-05-14 |
2015-11-19 |
Ischemix, LLC |
Formulations Comprising Lipoyl Compounds
|
|
WO2015174948A1
(en)
|
2014-05-14 |
2015-11-19 |
Ischemix, LLC |
Formulations comprising lipoyl compounds
|
|
AU2018258158A1
(en)
*
|
2017-04-25 |
2019-11-21 |
Ischemix Llc |
Compositions and methods for treating traumatic brain injury
|